Skip to main content
    • Aa
    • Aa

Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract

  • Annis O. Mechan (a1), Ann Fowler (a1), Nicole Seifert (a1), Henry Rieger (a1), Tina Wöhrle (a1), Stéphane Etheve (a1), Adrian Wyss (a1), Göde Schüler (a1), Biagio Colletto (a1), Claus Kilpert (a1), James Aston (a2), J. Martin Elliott (a2), Regina Goralczyk (a1) and M. Hasan Mohajeri (a1)...

A healthy, balanced diet is essential for both physical and mental well-being. Such a diet must include an adequate intake of micronutrients, essential fatty acids, amino acids and antioxidants. The monoamine neurotransmitters, serotonin, dopamine and noradrenaline, are derived from dietary amino acids and are involved in the modulation of mood, anxiety, cognition, sleep regulation and appetite. The capacity of nutritional interventions to elevate brain monoamine concentrations and, as a consequence, with the potential for mood enhancement, has not been extensively evaluated. The present study investigated an extract from oregano leaves, with a specified range of active constituents, identified via an unbiased, high-throughput screening programme. The oregano extract was demonstrated to inhibit the reuptake and degradation of the monoamine neurotransmitters in a dose-dependent manner, and microdialysis experiments in rats revealed an elevation of extracellular serotonin levels in the brain. Furthermore, following administration of oregano extract, behavioural responses were observed in mice that parallel the beneficial effects exhibited by monoamine-enhancing compounds when used in human subjects. In conclusion, these data show that an extract prepared from leaves of oregano, a major constituent of the Mediterranean diet, is brain-active, with moderate triple reuptake inhibitory activity, and exhibits positive behavioural effects in animal models. We postulate that such an extract may be effective in enhancing mental well-being in humans.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract
      Available formats
Corresponding author
*Corresponding author: Dr A. O. Mechan, fax +41 61 815 8740, email
Hide All
1Food and Health Forum (2008) The links between diet and behaviour: the influence of nutrition on mental health: Associate Parliamentary Food and Health Forum.
2Cornah D (2006) Feeding Minds: the Impact of Food on Mental Health. London: Mental Health Foundation.
3Van de Weyer C (2005) Changing Diets, Changing Minds: How Food Affects Mental Well Being and Behaviour. London: Sustain.
4Fernstrom JD (1990) Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1, 508517.
5Wurtman RJ & Fernstrom JD (1975) Control of brain monoamine synthesis by diet and plasma amino acids. Am J Clin Nutr 28, 638647.
6Frederick AL & Stanwood GD (2009) Drugs, biogenic amine targets and the developing brain. Dev Neurosci 31, 722.
7Jayanthi LD & Ramamoorthy S (2005) Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7, E728E738.
8Lucki I (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44, 151162.
9Missale C, Nash SR, Robinson SW, et al. (1998) Dopamine receptors: from structure to function. Physiol Rev 78, 189225.
10Haskell CF, Scholey AB, Jackson PA, et al. (2008) Cognitive and mood effects in healthy children during 12 weeks' supplementation with multi-vitamin/minerals. Br J Nutr 100, 10861096.
11Kennedy DO, Scholey AB, Tildesley NT, et al. (2002) Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav 72, 953964.
12Tildesley NT, Kennedy DO, Perry EK, et al. (2005) Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiol Behav 83, 699709.
13Tildesley NT, Kennedy DO, Perry EK, et al. (2003) Salvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers. Pharmacol Biochem Behav 75, 669674.
14Scholey AB, Tildesley NT, Ballard CG, et al. (2008) An extract of Salvia (sage) with anticholinesterase properties improves memory and attention in healthy older volunteers. Psychopharmacology (Berlin) 198, 127139.
15Ofir R, Tamir S, Khatib S, et al. (2003) Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci 20, 135140.
16Yáñez M, Fraiz N, Cano E, et al. (2006) Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun 344, 688695.
17Dhingra D & Sharma A (2006) Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry 30, 449454.
18Dhingra D, Parle M & Kulkarni SK (2004) Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol 91, 361365.
19de Moraes Pultrini A, Galindo LA & Costa M (2006) Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice. Life Sci 78, 17201725.
20Bergström LS & Lynöe N (2008) Enhancing concentration, mood and memory in healthy individuals: an empirical study of attitudes among general practitioners and the general population. Scand J Public Health 36, 532537.
21Fowler A, Seifert N, Acker V, et al. (2006) A nonradioactive high-throughput/high-content assay for measurement of the human serotonin reuptake transporter function in vitro. J Biomol Screen 11, 10271034.
22Qian Y, Galli A, Ramamoorthy S, et al. (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17, 4557.
23Holt A, Sharman DF, Baker GB, et al. (1997) A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem 244, 384392.
24White HL, Scates PW & Cooper BR (1996) Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 58, 13151321.
25Yamada M & Yasuhara H (2004) Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25, 215221.
26Lucki I, Dalvi A & Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155, 315322.
27Porsolt RD, Bertin A & Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229, 327336.
28Njung'e K & Handley SL (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38, 6367.
29Njung'e K & Handley SL (1991) Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol 104, 105112.
30Londei T, Valentini AMV & Leone VG (1998) Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour. Behav Brain Res 94, 249254.
31Broekkamp CL, Rijk HW, Joly-Gelouin D, et al. (1986) Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur J Pharmacol 126, 223229.
32Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15, 695699.
33Kreiss DS, Wieland S & Lucki I (1993) The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52, 295301.
34Malagié I, Trillat AC, Jacquot C, et al. (1995) Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur J Pharmacol 286, 213217.
35Felton TM, Kang TB, Hjorth S, et al. (2003) Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 367, 297305.
36Maione S, Palazzo E, Pallotta M, et al. (1997) Effects of imipramine on raphe nuclei and prefrontal cortex extracellular serotonin levels in the rat. Psychopharmacology (Berl) 134, 401405.
37Rutter JJ & Auerbach SB (1993) Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 265, 13191324.
38Paxinos G & Watson C (1986) The Rat Brain in Stereotaxic Coordinates. London: Academic Press.
39Carlier PR, Lo MM, Lo PC, et al. (1998) Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group. Bioorg Med Chem Lett 8, 487492.
40Skolnick P, Popik P, Janowsky A, et al. (2003) Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor. Eur J Pharmacol 461, 99104.
41Skolnick P, Popik P, Janowsky A, et al. (2003) “Broad spectrum” antidepressants: is more better for the treatment of depression? Life Sci 73, 31753179.
42Nutt DJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69, Suppl. E1, 47.
43Cryan JF, Valentino RJ & Lucki I (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29, 547569.
44Sillaber I, Panhuysen M, Henniger MS, et al. (2008) Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology (Berl) 200, 557572.
45Hirano K, Kimura R, Sugimoto Y, et al. (2005) Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. Br J Pharmacol 144, 695702.
46Hascoët M, Bourin M & Nic Dhonnchadha BA (2000) The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test. Pharmacol Biochem Behav 67, 4553.
47Bourin M, Redrobe JP, Hascoët M, et al. (1996) A schematic representation of the psychopharmacological profile of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 20, 13891402.
48Mason SS, Baker KB, Davis KW, et al. (2009) Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. Eur J Pharmacol 602, 306315.
49Kulkarni SK & Dhir A (2007) Effect of various classes of antidepressants in behavioral paradigms of despair. Prog Neuropsychopharmacol Biol Psychiatry 31, 12481254.
50Nicolas LB, Kolb Y & Prinssen EP (2006) A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur J Pharmacol 547, 106115.
51Kobayashi T, Hayashi E, Shimamura M, et al. (2008) Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study. Psychopharmacology (Berl) 197, 567580.
52Li X, Morrow D & Witkin JM (2006) Decreases in nestlet shredding of mice by serotonin uptake inhibitors: comparison with marble burying. Life Sci 78, 19331939.
53Bourin M & Hascoët M (2003) The mouse light/dark box test. Eur J Pharmacol 463, 5565.
54Melo FHC, Venâncio ET, de Sousa DP, et al. (2010) Anxiolytic-like effect of carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission. Fundam Clin Pharmacol 24, 437443.
55Machado DG, Bettio LE, Cunha MP, et al. (2009) Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 33, 642650.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 27
Total number of PDF views: 225 *
Loading metrics...

Abstract views

Total abstract views: 469 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 19th October 2017. This data will be updated every 24 hours.